Next-generation anti-PD-L1/IL-15 immunocytokine elicits superior antitumor immunity in cold tumors with minimal toxicity.
Shi W, Liu N, Liu Z, Yang Y, Zeng Q, Wang Y, Song L, Hu F, Fu J, Chen J, Wu M, Zhou L, Zhu F, Gong L, Zhu J, Jiang L, Lu H.
Shi W, et al. Among authors: hu f.
Cell Rep Med. 2024 Apr 25:101531. doi: 10.1016/j.xcrm.2024.101531. Online ahead of print.
Cell Rep Med. 2024.
PMID: 38697105
Free article.